STAT+: Otsuka kidney drug slowed loss of function, but less than expected, in late-stage trial

How 1 sources are covering this

• STATCenter·8d ago

  STAT+: Otsuka kidney drug slowed loss of function, but less than expected, in late-stage trial

  Otsuka’s Voyxact slowed the loss of kidney function after one year in patients with a chronic autoimmune kidney disease, but the benefit was less than expected.

  Read at STAT →